Fukuda Denshi Co., Ltd. (TYO:6960)
6,430.00
-120.00 (-1.83%)
Mar 11, 2025, 3:30 PM JST
Fukuda Denshi Revenue
Fukuda Denshi had revenue of 35.08B JPY in the quarter ending December 31, 2024, with 7.23% growth. This brings the company's revenue in the last twelve months to 140.46B, up 0.02% year-over-year. In the fiscal year ending March 31, 2024, Fukuda Denshi had annual revenue of 140.32B with 4.21% growth.
Revenue (ttm)
140.46B
Revenue Growth
+0.02%
P/S Ratio
1.33
Revenue / Employee
40.80M
Employees
3,443
Market Cap
185.37B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 140.32B | 5.68B | 4.21% |
Mar 31, 2023 | 134.65B | 2.55B | 1.93% |
Mar 31, 2022 | 132.10B | -14.66B | -9.99% |
Mar 31, 2021 | 146.76B | 13.36B | 10.02% |
Mar 31, 2020 | 133.39B | 3.62B | 2.79% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,170.61B |
Takeda Pharmaceutical Company | 4,579.02B |
Daiichi Sankyo Company | 1,795.99B |
HOYA Corporation | 837.44B |
Otsuka Holdings | 2,329.86B |
Terumo | 1,011.15B |
Astellas Pharma | 1,867.63B |
Olympus | 993.33B |